CELLINK to acquire precision dispensing company Scienion AG AM Industry
Bioprinting company CELLINK has entered into an agreement with the owners of Scienion AG, a German life science company focusing on precision dispensing technologies, to acquire all shares for a purchase price on cash- and debt-free basis of 80 million euros. Of these, 40 million euros will be paid in 2,814,032 newly issued shares of series B in CELLINK and the remainder in cash.